CAR-T Cell Engineering: In Vivo Cancer Therapy
Revolutionary In Vivo CAR-T Therapy Shows Promise for Multiple Myeloma Patients In a significant leap forward for cancer treatment, early clinical data reveals that a novel in vivo CAR-T cell therapy is demonstrating encouraging results in patients battling multiple myeloma. This innovative approach, which engineers immune cells directly within the patient’s body, bypasses the complex … Read more